Kalra_2014_Cancer.Res_74_7003

Reference

Title : Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion - Kalra_2014_Cancer.Res_74_7003
Author(s) : Kalra AV , Kim J , Klinz SG , Paz N , Cain J , Drummond DC , Nielsen UB , Fitzgerald JB
Ref : Cancer Research , 74 :7003 , 2014
Abstract : Kalra_2014_Cancer.Res_74_7003
ESTHER : Kalra_2014_Cancer.Res_74_7003
PubMedSearch : Kalra_2014_Cancer.Res_74_7003
PubMedID: 25273092

Related information

Citations formats

Kalra AV, Kim J, Klinz SG, Paz N, Cain J, Drummond DC, Nielsen UB, Fitzgerald JB (2014)
Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion
Cancer Research 74 :7003

Kalra AV, Kim J, Klinz SG, Paz N, Cain J, Drummond DC, Nielsen UB, Fitzgerald JB (2014)
Cancer Research 74 :7003